Regeneron Insider Trading Reveals Confidence, Not Crisis: What Investors Must Know
Insider Fenimore’s 2026 Regeneron trades show routine portfolio balancing, not a sell‑off, hinting continued confidence in the biotech’s strong fundamentals.
3 minutes to read